AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination ↧ ↧ AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug... AstraZeneca and Daiichi Sankyo have entered into a clinical collaboration with Summit Therapeutics to test their cancer drug, Datroway, in combination with Summit's ivonescimab across multiple tumour types, including lung and breast cancers.
published
AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination ↧
Open the original public source →
Latest documented BWB result
$APP market result
Sold the $280 10/9 Calls on $APP for $7.80
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.